Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Trying to look at the positives

<< Previous

Bullboard Posts

Next >>

Comment by SABBOBCATon Mar 08, 2023 4:06pm

47 Views

Post# 35326716

RE:RE:RE:RE:RE:RE:RE:RE:Trying to look at the positives

They are under blackout again until Q1 results are released. So insiders are unable to buy or execute options at this time.

that is why I found it curious that they waited until Feb 28 to release YE financials. Was it truely a delay due to Marathon negotiations etc, or was it because the are in negotiations with a partner and they didn't want to have to tip their hand as to why they are in blackout?

Again, more speculative tea leaves. I wish we had a stronger foundation to build a recovery on, but we are left to rot on these message boards instead.

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects